Dr. Rodney Pollary, MD

NPI: 1902805500
Total Payments
$28,427
2024 Payments
$27,040
Companies
2
Transactions
15

Payment Breakdown by Category

Consulting$27,940 (98.3%)
Other$475.00 (1.7%)
Food & Beverage$12.07 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $27,940 13 98.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $475.00 1 1.7%
Food and Beverage $12.07 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $28,415 14 $0 (2024)
Tris Pharma Inc $12.07 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $27,040 12 Takeda Pharmaceuticals U.S.A., Inc. ($27,040)
2023 $1,375 2 Takeda Pharmaceuticals U.S.A., Inc. ($1,375)
2018 $12.07 1 Tris Pharma Inc ($12.07)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
01/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,253.33 General
12/15/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $900.00 General
10/19/2023 Takeda Pharmaceuticals U.S.A., Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $475.00 General
05/09/2018 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $12.07 General
Category: ADHD

About Dr. Rodney Pollary, MD

Dr. Rodney Pollary, MD is a Pediatrics healthcare provider based in Lehi, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902805500.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodney Pollary, MD has received a total of $28,427 in payments from pharmaceutical and medical device companies, with $27,040 received in 2024. These payments were reported across 15 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($27,940).

Practice Information

  • Specialty Pediatrics
  • Location Lehi, UT
  • Active Since 07/18/2005
  • Last Updated 01/16/2024
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1902805500

Products in Payments

  • Dyanavel XR (Drug) $12.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Lehi